<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04770675</url>
  </required_header>
  <id_info>
    <org_study_id>CIS-20</org_study_id>
    <nct_id>NCT04770675</nct_id>
  </id_info>
  <brief_title>Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.</brief_title>
  <official_title>A Prospective, Multicenter, Post Market Study to Collect Data for Software Recognizing the Anatomical Structures as Well as Abnormalities in the Lung During a Bronchoscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qmed Consulting A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ambu A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Qmed Consulting A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim is to develop a software algorithm that has the capacity to detect the normal&#xD;
      18 anatomical structures of the lung by using the position of the scope during the&#xD;
      bronchoscopy procedure and using existing bronchoscopy technology.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      2.000 subjects, preferable 150-200 number of patients per site. The 2.000 videos will be&#xD;
      divided into an 80%/20% split (training and testing). It is a wish to obtain a spread of&#xD;
      videos coming from across Europe, preferable from Germany, France and Denmark, with up to 800&#xD;
      videos coming from Denmark&#xD;
&#xD;
      The patient population indicated are patients indicated for full airway bronchoscopy. Of this&#xD;
      group it is the aim to enrol the following:&#xD;
&#xD;
        1. Patients with obstructing tumors (when tumor blocks the view of the camera) - no more&#xD;
           than 5% (120 patients) of studies&#xD;
&#xD;
        2. Bronchoscopies on indication of haemoptysis (active bleeding) - no more than 5% (120&#xD;
           patients) of studies&#xD;
&#xD;
        3. Patients with stents or valves - no more than 5% (120 patients) of studies&#xD;
           bronchoscopies.&#xD;
&#xD;
        4. Patients with former lung operations, partial or full resections - no more than 2% (48&#xD;
           patients).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of anatomical segments accessed during bronchoscopy</measure>
    <time_frame>1 day</time_frame>
    <description>accurate photo documentation of all 18 anatomical segments +/- abnormalities</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of anatomical segments identified</measure>
    <time_frame>1 day</time_frame>
    <description>Identified anatomical segments by the core lab/ Identified anatomical segments by the Machine Learning (after training, using the test videos).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of total number of lesions detected</measure>
    <time_frame>1 day</time_frame>
    <description>total lesions detected by the core lab/ total lesions detected by Machine Learning (after training, using the test videos).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of sections and lesions detected by core lab and machine learning</measure>
    <time_frame>1 day</time_frame>
    <description>Anatomical sections + lesions detected by core lab versus anatomical sections + lesions detected by machine learning</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Tumor</condition>
  <condition>Hemoptysis</condition>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <description>Any subject who is scheduled to undergo bronchoscopy as per routine clinical practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Bronchoscopy</intervention_name>
    <description>All subjects who are scheduled for a bronchoscopy may be eligible.</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The bronchoscope is used to confirm or exclude a diagnosis in adult patients with airway&#xD;
        complaints to identify a potential disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Oral and written participant information has been given (NA for Denmark)&#xD;
&#xD;
          2. The subject has signed informed consent (NA for Denmark)&#xD;
&#xD;
          3. Patients indicated for full airway bronchoscopy (identifying all 18 anatomical&#xD;
             segments)&#xD;
&#xD;
          4. Patients older than 18&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject with serious lung disease which investigator considers not appropriate for&#xD;
             this examination.&#xD;
&#xD;
          2. Lack of patient cooperation for bronchoscopy (patient with mental disorders,&#xD;
             dysgnosia, psychological disorderâ€¦)&#xD;
&#xD;
          3. Subjects unable to give consent (NA for Denmark)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Perch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helene Quie</last_name>
    <phone>+45 56 64 10 10</phone>
    <email>hq@qmed-consulting.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Perch, MD</last_name>
      <email>Michael.Perch@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2021</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bronchoscope</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemoptysis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Provide data to Ambu A/S that can not be identified without the identification log.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2 years after study end</ipd_time_frame>
    <ipd_access_criteria>restricted access with user accounts to electronic data capture system</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

